| Name | Title | Contact Details |
|---|---|---|
Stacey Santo |
Chief Experience and Innovation Officer | Profile |
Sarah Richardson |
Chief Information Officer | Profile |
Paul Wolf |
Information Security Officer | Profile |
American Health Care Software is a South Burlington, VT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
careMESH is a first-of-its-kind healthcare communications platform bringing together a national provider directory, admit/discharge notifications, secure communications, and transition of care workflows into a single service. careMESH connects the care continuum by allowing any provider working with any electronic health record to communicate and collaborate with any other, instantly. careMESH`s cloud-based services efficiently allow hospitals and health systems, health information exchanges, public health agencies, and physician groups to communicate about patients, maintain complete control over when and where information is shared, and rapidly reduce reliance on outdated tools such as fax and phone calls.
Fallon Ambulance Service was founded in 1936 by James Fallon Sr. and remains a family operated business to this day. Fallon Ambulance employs more than 525 personnel, including 125 Paramedics and 375 EMTs, and operates 115 vehicles. The company provides
Texas Medical Association was organized by 35 physicians in 1853 to serve the people of Texas in matters of medical care, prevention and cure of disease, and the improvement of public health. Today, with more than 56,000 physician and medical student members, TMA is the nation`s largest state medical society. TMA`s key objective is to improve the health of all Texans.
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.